All of the obtained compounds were tested in a JNK1 enzymatic inhibition assay and in a cell-based assay by measuring the inhibition of the TNFα (tumor necrosis factor)-stimulated phosphorylation of c-Jun in HepG2 (human liver cancer) cells. Here, TNF is linked to liver cancer.